An observational study in Rheumatoid Arthritis and Interstitial Lung Disease, sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest. Recruiting at 3 sites in Hungary. Open to participants aged 40 Years and older. Per ClinicalTrials.gov, last updated 2022-05-31.
Sponsored by Polyclinic of the Hospitaller Brothers of St. John of God, Budapest · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 204 studies in Arthritis, Rheumatoid with a site in Hungary — 4 open to participants now, 11 under way, 2 of them phase 3. Arthritis, Rheumatoid · Hungary.
Among the 204 studies in Arthritis, Rheumatoid with a site in Hungary, this one is the 3rd largest by planned enrollment of the 11 observational ones that give a count, is one of 4 that started in 2022, is one of 11 observational ones, reaches primary completion later than 4 of the 10 other live ones, and was the 191st registered.
3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.
Browse Arthritis, Rheumatoid studies →4 of the 204 studies in Arthritis, Rheumatoid with a site in Hungary are open now. Recruiting first, the newest first:
AstraZeneca · Sites in Hungary, United States, Argentina and 14 more countries
Ages 18+
AbbVie · Sites in Hungary, United States, Canada and 9 more countries
Ages 18+
Semmelweis University · Sites in Hungary
Ages 18–100
A study can be open while its sites in Hungary have not opened yet or have stopped. Only those recruiting at a site in Hungary →
Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.
This study: 40 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
204 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 15 · Phase 2 90 · Phase 3 79 · Phase 4 12
First in 2002; this study’s year is marked. 4 started in 2022.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 176 across 1,017 observational studies indexed under Arthritis, Rheumatoid.
Median enrollment 350 across the 193 interventional studies, 353 across the 11 observational. Of the 192 that completed or were terminated, 142 (74%) have results posted.
This tab as a report to print or save as PDF → With an account.
198 of 204 have an industry lead sponsor. The 10 most frequent:
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest is the lead sponsor of 7 studies on the registry; 2 are open to participants now.
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest has 1 study filed under Arthritis, Rheumatoid — fewer than ten, so there is no comparison to draw.
5 of the studies in Arthritis, Rheumatoid with a site in Hungary that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05391100Polyclinic of the Hospitaller Brothers of St. John of God, BudapestScreening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease | 2026-12 |
| NCT06972446AbbVieA Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis | 2027-02 |
| NCT05657847Semmelweis UniversityNovel Complex Radiodiagnostics of Peripherial Arthropathies | 2027-02-01 |
| NCT06754462Immunovant Sciences GmbHA Study to Evaluate the Efficacy, Safety, and Tolerability of IMVT-1402 in Adult Participants With Active, Difficult to Treat Rheumatoid Arthritis | 2027-09 |
| NCT07276581AstraZenecaA Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | 2027-11-12 |
Add all 5 to your calendar (.ics) → With an account.
Among the 204 studies in Arthritis, Rheumatoid with a site in Hungary, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
The quantitative and qualitative analysis of RA lung involvement in the Hungarian population
Interstitial lung disease (ILD) accounts for a significant proportion of mortality and morbidity in rheumatoid arthritis (RA). The aim of this prospective longitudinal study is to asess the interstitial lung involvement in Hungarian rheumatoid arthritis patients. Laboratory markers, X-ray based imaging methods, pulmonological functional tests, QOL questionnaire and sleep quality assessement questionnaire are used to estimate the interstitial lung disease. Also smaller cross-sectional studies about the imaging parameters and a national register is planned to be created based on these data.
RA patients with regular follow-ups at Polyclinic of Hospitaller Brothers of St. John of God, Budapest
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Prevalence of ILD
detection of ILD with imaging methods
Time frame: From baseline to at least 5 years
pattern of ILD
to characterize the ILD patterns based on imaging methods
Time frame: From baseline to at least 5 years
Correlation with biomarkers
correlation of the imaging results with respiratory function, disease activity and laboratory markers
Time frame: From baseline to at least 2 years
Plan to share: No
Started Feb 2022 (actual). Primary completion is estimated for Dec 2026, 58 months after the start.
Of 235 non-industry observational studies under Arthritis, Rheumatoid, half reached primary completion within 42 months of starting (the median), counting those still running; a quarter within 19 and three quarters within 122. This study's planned 58 months is above that.
Counting every sponsor, half of 390 studies reached it within 50 months; a quarter within 25 and three quarters within 113.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Polyclinic of the Hospitaller Brothers of St. John of God, Budapest